Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CE7R CAR-T cells |
Trade Name | |
Synonyms | CD171 CAR+ T Cells|CD171-specific CAR-CD28 zeta-4-1-BB-EGFRt-expressing T cells |
Drug Descriptions |
CE7R CAR-T cells are autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD171 and containing CD28, CD3zeta, and TNFRSF9 (4-1BB) signaling domains and truncated EGFR, which potentially induces cytotoxicity in CD171-expressing tumors (PMID: 27390347). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C119746 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CE7R CAR-T cells | CE7R CAR-T cells | 0 | 1 |